pteridines has been researched along with Familial Nonmedullary Thyroid Cancer in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Volasertib treatment reduced cells in the S phase and increased cells in the G2/M phase." | 1.51 | Targeting PLKs as a therapeutic approach to well-differentiated thyroid cancer. ( Chou, TC; Huang, YT; Lin, JD; Lin, SF; Wong, RJ; Yeh, CN, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, SF | 1 |
| Lin, JD | 1 |
| Yeh, CN | 1 |
| Huang, YT | 1 |
| Chou, TC | 1 |
| Wong, RJ | 1 |
1 other study available for pteridines and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Targeting PLKs as a therapeutic approach to well-differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benz | 2019 |